Patent · US Active

PCV2 Mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions

US9669086B2 · kind B2 · utility

1Cited by

78References

11Claims

0Family size

Assignee

BOEHRINGER INGELHEIM VETMEDICA GMBH · DE

Inventors

Michael B. Roof · Ames, US
Marc Allan Eichmeyer · Bondurant, US

Key dates

Filing date	Mar 9, 2015
Grant date	Jun 6, 2017
Priority date	—
Expiry date	Mar 9, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/10071
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Multivalent combination vaccines are provided which include an immunological agent effective for reducing the incidence of or lessening the severity of M. hyo infection, preferably M. hyo bacterin, or an immunogenic composition comprising M. hyo bacterin, and at least one immunogenic active component of another disease-causing organism in swine, preferably PCV2 wherein the preferred PCV2 antigen for such a multivalent vaccine is PCV2 ORF 2 protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.